14 companies backed by Alexandria Venture Investments, including Avalo, ARTBIO, Dualitas Therapeutics. Each links to its full verified cap-table syndicate.
Alexandria Venture Investments accounts for 81 tracked companies with verified cap-table data, 81 of which disclose round sizes totalling $12B. The median disclosed raise is $123M, and the largest is Neumora Therapeutics at $500M, ahead of TORL BioTherapeutics ($450M) and Prometheus Biosciences ($400M).
The names that recur most often on these portfolio cap tables are Alexandria Venture Investments (81 companies), ARCH Venture Partners (15 companies), GV (10 companies), Polaris Partners (8 companies), Janus Henderson Investors (8 companies), Invus (7 companies). By latest disclosed round, the market skews Series A (32), Series B (27), Series C (10), Seed (4).
Companies tracked: 81
Disclosed funding total: $12B across 81 companies
Median disclosed raise: $123M
Largest raise: Neumora Therapeutics — $500M
Stage mix: Series A 32 · Series B 27 · Series C 10 · Seed 4
Most recent dated round: 2026-06-10
Best funded Alexandria Venture Investments companies
